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INTRODUCTION
Cervical cancer is the second most common female
cancer in Indonesia.1 Its incidence in Indonesia is
estimated to be 100 per 100,000 population, or
around 230,000 cases per year, and more than
70% of those presents to the hospital at an ad-
vanced stage.2 Development of cervical cancer due
to HPV infection involves a long process. Thus, cer-
vical cancer is a cancer that could potentially be
prevented by early detection and prompt treat-
ment of precancerous lesions.3
Persistent infection of human papillomavirus
(HPV), high-risk HPV (HR-HPV) in particular, has
generally been accepted as the etiology of cervical
cancer. Despite this fact, there is still little know-
ledge on the prevalence of HPV in Indonesia. Se-
veral studies have reported the incidence of HPV
infection in the general population in Indonesia,
ranging from 11.4% to 25.4%.4,5 The common
types of HR-HPV in the population are 16, 18, 51
and 52, but the exact prevalence varies in each
study.4-6 Based on this, we conducted a study to
Abstract
Objective: Over 200 types of human papillomavirus (HPV) have
been recognized on the basis of DNA sequence. Multiple infection is
more prone to be persistent than single infection. The purpose of
this study is to assess the variation of HPV types and their preva-
lence among negative VIA as normal population in Indonesian wo-
men.
Method: We processed cervical swabs from 1,214 patients with
negative VIA. HPV DNA and its genotypes were detected using PCR
based INNO-Lipa HPV DNA test. We also classified whether each in-
fection is single or multiple.
Result: From 1,214 women with negative VIA, 39 (3.21%) samples
were positive for HPV DNA. Among them, we detected 19 types of
HPV, consisting of 13 types of high-risk HPV, 5 types of low-risk HPV,
and 1 type of unknown HPV (type X). The most prevalent type was
HPV type 52 (18.31%), followed by type 39 and X with the same pro-
portion (9.86%), and HPV type 16, 18, and 74 (each 8.45%). Of the
total 39 HPV-positive samples, 17 (43.6%) showed multiple-type in-
fection and 22 (56.4%) showed single-type infection. The majority
of single infection involves high-risk-HPV. The remaining were type
6, 44, 18, 51 and 66, with each single-type infection showing a preva-
lence of 4.54%.
Conclusion: Our study shows that single HPV infection among the
negative VIA population are dominated by high-risk type HPV (types
52, 39, 16, and 18). Single infection was more often encountered
than multiple infection.
[Indones J Obstet Gynecol 2014; 4: 211-215]
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Abstrak
Tujuan: Terdapat lebih dari 200 tipe HPV yang dikenal berdasarkan
sekuens DNA. Infeksi HPV multipel memiliki kecenderungan lebih un-
tuk menjadi persisten dibandingkan dengan infeksi tunggal. Tujuan
dari penelitian ini adalah untuk menilai variasi tipe HPV dan preva-
lensinya pada perempuan dengan IVA negatif sebagai populasi nor-
mal pada perempuan Indonesia.
Metode: Kami memeriksa apusan serviks dari 1.214 pasien dengan
IVA negatif. DNA HPV dan genotipnya dideteksi dengan menggunakan
tes DNA HPV INNO-Lipa berbasis PCR. Kami juga melakukan klasifi-
kasi infeksi HPV menjadi infeksi tunggal atau multipel.
Hasil: Dari 1.214 wanita dengan IVA negatif, ditemukan 39 sampel
(3,21%) dengan DNA HPV positif. Terdeteksi 19 tipe HPV, yang terdiri
dari 13 tipe HPV risiko tinggi, 5 tipe HPV risiko rendah, dan 1 tipe HPV
yang belum diketahui klasifikasinya (tipe X). Tipe HPV yang paling tinggi
prevalensinya adalah HPV 52 (18,31%), diikuti tipe 39 dan X dengan pro-
porsi yang sama (9,86%), dan HPV tipe 16, 18, dan 74 (masing-masing
8,45%). Dari total 39 subjek yang positif untuk DNA HPV, 17 (43,6%)
merupakan infeksi multipel, sedangkan 22 (56,4%) subjek lainnya ada-
lah infeksi tunggal. Infeksi tunggal didominasi oleh HPV risiko tinggi.
Sisanya menunjukkan HPV tipe 6, 44, 18, 51, dan 66, dengan prevalensi
masing-masing 4,54%.
Kesimpulan: Studi ini menunjukkan bahwa infeksi HPV tunggal yang
ditemukan didominasi oleh HPV risiko tinggi (HPV tipe 52, 39, 16, dan
18). Infeksi tunggal lebih sering terjadi dibandingkan infeksi multipel.
[Maj Obstet Ginekol Indones 2014; 4: 211-215]
Kata kunci: DNA HPV, genotip HPV, infeksi multipel, infeksi tunggal,
IVA Negatif
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assess the variation of HPV types and their preva-
lence among VIA-negative women as a normal po-
pulation in Indonesian women.
METHODS
We performed a community-based, cross-sectional
study. Sample collection was carried out at the Ob-
stetrics and Gynecology outpatient clinic, Dr. Cipto
Mangunkusumo General Hospital, Jakarta and
other health facilities designated in the "See and
Treat" Female Cancer Program (FCP) in Jakarta,
from January to September 2012. Laboratory pro-
cessing and examination were conducted at the
Department of Gynecology and Department of
Pathology, Leiden Universitair Medisch Centrum
(LUMC), The Netherlands.
This study has been approved by the Ethics
Committee of Faculty of Medicine, University of
Indonesia - Dr. Cipto Mangunkusumo General Hos-
pital. Each patient participating in this study signed
an informed consent.
Patients included in this study were married wo-
men aged 20-50 years with negative VIA. Pregnant
women, women with history of promiscuity, mul-
tiple partners, and intravenous drug use were ex-
cluded. After complete history-taking, a cervical
swab was obtained and then inserted into a tube
containing Phosphate Buffered Saline (PBS) from
Gibco®. Catalog Number 10010-023). Subsequent
VIA examination using 3-5% acetic acid was con-
ducted by trained health professionals in the par-
ticular health facilities. If the VIA result was nega-
tive, the cervical swab was then processed for de-
tection of HPV DNA. Patient with acetowhite lesion
or cervical cancer were excluded; patients with
acetowhite lesion were offered cryotherapy and
patients with cervical cancer were referred to the
Gynecologic Oncology outpatient clinic, Dr. Cipto
Mangunkusumo General Hospital.
HPV DNA examination was performed by a
trained doctor and a lab technician expert in HPV.
It was conducted in two steps using the INNO-LiPA
HPV Genotyping Extra Kit (Fujirebio Europe). The
initial step was HPV PCR (SPF10) followed by elec-
trophoresis to detect the presence of HPV DNA. If
the result was positive, it would be followed by
HPV genotyping by hybridization to determine the
HPV type.
The main outcome measured in this study is the
HPV genotype found in VIA-negative patients. In
addition, we also classified whether each infection
was single or multiple. Data analysis was per-
formed using Statistical Program for Social Scien-
ces version 20.0 (SPSS Inc., Chicago, Illinois).
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n = 39Figure 1. Flow of subjects.
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RESULTS
We obtained 1,279 VIA-negative subjects, but 65
subjects were excluded due to incomplete data.
HPV DNA examination was conducted on the re-
maining 1,214 subjects. HPV DNA was positive in
39 (3.21%) subjects and negative in 1175 (96.79%)
subjects (Figure 1). The mean age of the subjects
in this study was 40.9 9.3 years.
We found that the prevalence of HPV infection
in the VIA negative group is relatively low (3.21%).
Nineteen HPV types were detected, comprising of
13 HR-HPV, 5 LR-HPV, and 1 unknown type (HPV
X). Single HPV infection was found in 22 (56.41%)
subjects, while multiple HPV infection was found
in 17 subjects (43.59%), as shown in Table 1. The
most prevalent type of HPV was HPV 52 (18.31%).
Result of HPV genotyping is shown in Table 2.
Table 1. HPV DNA Test Results
Variable n %
HPV DNA (+) 39 3.21
HPV DNA (-) 1175 96.79
Types of HPV detected
HR-HPV 13 types
LR-HPV 5 types
HPV-X 1 type
Types of HPV Infection
Single infection 22 56.41
Multiple infection 17 43.59
Table 2. Types of HPV Detected with HPV Genotyping
HPV Type n (71) %
HPV 52 13 18.31
HPV 39 7 9.86
HPV X 7 9.86
HPV 16 6 8.45
HPV 18 6 8.45
HPV 74 6 8.45
HPV 44 3 4.22
HPV 54 3 4.22
HPV 66 3 4.22
HPV 6 1 1.41
HPV 31 1 1.41
HPV 51 2 1.41
HPV 53 1 1.41
HPV 56 2 1.41
HPV 58 2 1.41
HPV 68 2 1.41
HPV 69 2 1.41
HPV 71 2 1.41
HPV 73 2 1.41
DISCUSSION
Based on our knowledge, this is the first major
study to detect HPV DNA in the normal population,
defined as women who have been screened with
VIA and have negative results. We found a rela-
tively low prevalence of positive HPV DNA in nega-
tive VIA as normal population, around 3.21%. Clif-
ford et al found the range of positive HPV infection
in women with normal cytology from 11 countries
varied from 1.4% to 25.6% depending on the coun-
try.7 Our finding is on the lower end of that range.
Therefore in our study, VIA is comparable to Pap
test, and may even give better results. However, it
is important to note that VIA is unable to detect
lesions in the endocervix.8
Among 1,214 VIA-negative subjects in this study,
we detected 39 subjects (3.21%) with positive HPV
DNA and performed hybridization technique for
genotyping examination. Nineteen types of HPV
were detected, namely HPV types 6, 16, 18, 31, 39,
44, 51, 52, 53, 54, 56, 58, 66, 68, 69, 71, 73, 74, and
one of unknown type (HPV X). When classified,
there were 13 types (68.42%) HR-HPV, namely
types 16, 18, 31, 39, 51, 52, 56, 58, 66, 68, 69, 71,
and 73; while 5 types of LR-HPV were detected
(26.32%), HPV types 6, 44, 53, 54, and 74. HPV X
(5.26%) is an unknown HPV type classification.
The most frequent type of HPV detected were
type 52 (18.31%), followed by type 39 and X with
the same proportion (9.86%), and HPV type 16, 18,
and 74 (each 8.45%). In a large scale study in the
general population in three major cities in Indone-
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sia, Vet et al also reported similar results; where
the most commonly detected type of HPV was type
52 (23.2%), followed by HPV type 16 (18.0%), 18
(16.1%), and 39 (11.8%).5 Even though the preva-
lence of HPV infection in women with negative VIA
is relatively low (3.21%), but most (68.42%) were
infected by HR-HPV. This is an important fact for
clinicians in considering the management of pa-
tients with negative VIA.
Clifford et al reported that even though the over-
all prevalence of HPV in general and HPV 16 was
the highest in sub-Saharan Africa, the population
in Europe infected with HPV had higher chances of
being infected with HPV 16.7 In a study conducted
by Tabora et al in a population with normal cyto-
logy, 23 HPV types were detected, the most fre-
quent types being HPV 16, 51, 31, 18, and 11.9 An-
other study on 1,859 women with normal cytology
detected 32 different HPV types, including HPV
type X (0.4%).10
This research also consistently supports pre-
vious data that states HPV types 16 and 18 as HR-
HPV is apparently common in the asymptomatic
general population with the same proportion of the
population suffering from cervical cancer. HR-HPV
type 52 and 39 were the most-commonly identified
type, both in population with negative VIA and a
general population who has not been screened,
thus they should get special attention.
The proportion of single and multiple HPV in-
fection in our study was comparable. This finding
is not of significant importance, and other studies
have reported conflicting significance of single or
multiple HPV infections. Cuschieri et al found that
multiple HR-HPV infection is not more common in
high-grade squamous intraepithelial lesions (HSIL)
than in low-grade squamous intraepithelial lesions
(LSIL).11 Goodman et al12 and Campos et al13 re-
ported that persistence of HPV infection was not
significantly different between single and multiple
HPV infections. Trottier et al showed that multiple
HR- HPV infection increases the incidence of pre-
cancerous lesions within 4 years of monitoring.14
In contrast, Cuschieri et al showed that multiple
HPV infection do not lead to a higher risk of pre-
cancerous lesion within 2-3 years of monitoring,
compared to single infection of HR-HPV.15
CONCLUSION
Our study may add a new insight to the prevalence
of HPV in women, as we have previously screened
the subjects with VIA. Despite the low prevalence
(3.21%), most of the positive cases were infected
by high-risk HPV, particularly HPV 52, 39, 16, and
18. However, this fact should not inhibit the use of
VIA for widespread screening in Indonesia or other
countries with low resource settings, as it is still
the easiest and cheapest method of screening avai-
lable.
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